Inactive Instrument
GRN Holding Corporation Stock Other OTC
Stocks
GRNF
US36257K1097
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 2.25M 1.93M 1.81M 1.65M 3.1M 216M 3.14M 21.34M 8.32M 108M 8.46M 8.28M 358M | P/E 2023 * |
-
| P/E 2024 | -6.01x |
|---|---|---|---|---|---|
| Enterprise Value | 2.67M 2.28M 2.14M 1.96M 3.67M 255M 3.72M 25.24M 9.84M 128M 10.01M 9.79M 424M | EV / Sales 2023 |
-
| EV / Sales 2024 | - |
| Free-Float |
39.27% | Yield 2023 * |
-
| Yield 2024 | - |
| 1 day | -32.13% |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Sheikh
CEO | Chief Executive Officer | 56 | 2024-10-29 |
Matthew Dwyer
PSD | President | 61 | 2025-04-01 |
Shawn Burns
SAM | Sales & Marketing | - | 2020-02-20 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Sheikh
BRD | Director/Board Member | 56 | 2024-10-29 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -32.13% | -25.00% | - | - | 595K | |
| +1.09% | +5.26% | +4.52% | +26.24% | 51.61B | |
| -1.07% | +2.82% | +465.96% | +586.75% | 44.89B | |
| +1.47% | +9.79% | +35.92% | +21.40% | 42.77B | |
| +1.44% | +7.77% | +19.38% | +92.75% | 42.58B | |
| -0.93% | -4.33% | +16.18% | +53.76% | 31.82B | |
| +1.32% | +7.30% | +33.89% | +150.10% | 17.33B | |
| -0.60% | +1.93% | - | - | 16.63B | |
| +0.03% | +3.41% | +6.55% | +32.10% | 14.76B | |
| +1.28% | +5.41% | +82.40% | +47.43% | 14.09B | |
| Average | -2.81% | +4.43% | +83.10% | +126.32% | 30.72B | |
| Weighted average by Cap. | +0.49% | +4.72% | +99.57% | +146.30% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | - | - |
| Net income | -10.38K -8.89K -8.32K -7.62K -14.3K -994K -14.49K -98.33K -38.35K -499K -38.99K -38.14K -1.65M | -320K -275K -257K -235K -441K -30.66M -447K -3.03M -1.18M -15.4M -1.2M -1.18M -50.95M |
| Net Debt | -100K -85.66K -80.15K -73.37K -138K -9.57M -140K -947K -369K -4.81M -375K -367K -15.9M | 412K 353K 330K 302K 568K 39.45M 575K 3.9M 1.52M 19.82M 1.55M 1.51M 65.55M |
Employees
-
